Skip to main content

Want a detailed portfolio tracker?

Comparison Replimune Group (REPL) with Competitors

Replimune Group (REPL) industry is Biotechnology.

Debt-to-Equity
REPL50.14%
Industry28.27%
Upside+77.36%
Free Cash Flow Yield
REPL-35.01%
Industry-1.75%
Upside-33.27%
P/E
REPL-2.45
Industry-20.52
Upside+1806.67%
P/B
REPL4.98
Industry5.15
Upside-3.16%